Gennex Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gennex Laboratories Ltd. on BSE

Search Inside the pdf :

Gennex Laboratories Ltd.

22 Apr 2025

12.64

-1.40%

Company Update

Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

With reference to the captioned subject matter, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received from M/s. R&D Infotech Private Limited, Registrar and Transfer Agent of the Company for the quarter ended March 31, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

26 Mar 2025

12.64

-1.40%

SAST

Gennex Laboratories Ltd - 531739 - Closure of Trading Window

BSE India

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Securities of the Company shall remain closed from April 01, 2025 till 48 hours after the Public announcement through Board of Directors in their Meeting held for announcing the audited Financial Results for the Quarter and Year ended on March 31, 2025 along with other matters for which Trading Window is required to be closed. The Board Meeting date to approve the audited financial results of the Company for the quarter and year ending on March 31, 2025 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

24 Mar 2025

12.64

-1.40%

SAST

Gennex Laboratories Ltd - 531739 - Disclosures of reasons for encumbrance by promoter of listed companies …

BSE India

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 20, 2025 for Premier Fiscal Services Pvt Ltd

pdf

Gennex Laboratories Ltd.

24 Mar 2025

12.64

-1.40%

SAST

Gennex Laboratories Ltd - 531739 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 20, 2025 for Premier Fiscal Services Pvt Ltd

pdf

Gennex Laboratories Ltd.

20 Mar 2025

12.64

-1.40%

SAST

Gennex Laboratories Ltd - 531739 - Disclosures of reasons for encumbrance by promoter of listed companies …

BSE India

pdf

Gennex Laboratories Ltd.

20 Mar 2025

12.64

-1.40%

SAST

Gennex Laboratories Ltd - 531739 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 20, 2025 for Premier Fiscal Services Pvt Ltd

pdf

Gennex Laboratories Ltd.

03 Mar 2025

12.64

-1.40%

Corp. Note

GENNEX LABORATORIES LTD. - 531739 - Integrated Filing (Financial)

BSE India

Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 and BSE Notice No. 20250102-4 dated January 02, 2025 and your email dated March 03, 2025, please find herewith the report on Integrated Filing (Financial) for the Quarter and Nine months ended December 31. 2024. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

17 Feb 2025

12.64

-1.40%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015, please find enclosed herewith Newspaper Publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Nine months ended December 31, 2024 announced by the Board of Directors in its Meeting held on February 14, 2025. financial Results had been published in both Financial Express (English) and Saksham (Telugu - Local) on Sunday, Friday 16, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

14 Feb 2025

12.64

-1.40%

Result

GENNEX LABORATORIES LTD. - 531739 - Unaudited Financial Results For Quarter And Nine Months Ended December …

BSE India

In just concluded Meeting of Board of Directors, the Board considered and approved the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2024. 2. Limited Review Reports from the Statutory Auditors on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2024. 3. Resignation of Mr. Mohammed Khaleequr Rahman, Non-Executive Non-Independent Director of the Company. 4. Other Business items. We hereby submit that the Board Meeting had commenced at 4.00 PM and concluded at 6.15 PM. The intimation is also being uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

14 Feb 2025

12.64

-1.40%

Board Meeting

GENNEX LABORATORIES LTD. - 531739 - Board Meeting Outcome for Outcome Of The Board Meeting Of …

BSE India

In just concluded Meeting of Board of Directors, the Board considered and approved the following items 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2024 2. Limited Review Report from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2024. 3. Resignation of Mr. Mohammed Khaleequr Rahman, Non-Excutive and Non-Independent Director of the Company 4. Other Business items We hereby submit that the Board Meeting commenced at 4.00 PM and concluded at 6.15 PM. The intimation is also being uploaded on the Company Website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Is Gennex Laboratories Ltd. worth buying?

126 Votes:

Buy 83.33%

Sell 6.35%

Hold 10.32%